Lanean...
Pharmacological Management of High-risk Neuroblastoma in Children
BACKGROUND: Neuroblastoma is the most common extracranial solid tumor of childhood. It accounts for 15% of pediatric cancer deaths. Children with high-risk disease have a 3-year event-free survival rate of only 20%. Chemotherapy is the mainstay of the treatment of children with advanced neuroblastom...
Gorde:
| Argitaratua izan da: | Paediatr Drugs |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321778/ https://ncbi.nlm.nih.gov/pubmed/21692548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/11591630-000000000-00000 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|